Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for diagnosing human prion disease.

Gábor G Kovács1, Till Voigtländer, Ellen Gelpi

  • 1Institute of Neurology, Medical University of Vienna, and Austrian Reference Centre for Human Prion Diseases, Vienna, Austria.

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|June 5, 2004
PubMed
Summary

Human prion diseases, such as Creutzfeldt-Jakob disease (CJD), involve neurodegeneration due to abnormal prion protein (PrPSc) accumulation. Diagnosis relies on detecting PrPSc, with ongoing research exploring new biomarkers for early detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Altered EEG in Creutzfeldt-Jakob Disease: Improving Diagnostic Accuracy Using American Clinical Neurophysiology Society 2021 Criteria.

Neurology. Clinical practice·2026
Same author

Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Brainstem pathology in anti-IgLON5 disease: new insights into early events and tau progression.

Brain : a journal of neurology·2026
Same author

A novel PTEN variant causing hemimegalencephaly and focal nodular heterotopias in the developing human brain.

Epilepsia·2026
Same author

Variably Protease-Sensitive Prionopathy: Two New Cases With Motor Neuron-Dementia Syndrome.

Annals of clinical and translational neurology·2025

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Human prion diseases (PrD) are fatal neurodegenerative disorders characterized by neuronal loss and spongiform changes.
  • The hallmark pathology is the accumulation of abnormal prion protein (PrPSc), a misfolded conformer of the cellular prion protein (PrPC).
  • Prion diseases encompass sporadic, acquired, and familial forms, with Creutzfeldt-Jakob disease (CJD) being the most common.

Purpose of the Study:

  • To review the neuropathological hallmarks and diagnostic approaches for human prion diseases.
  • To differentiate between sporadic CJD and variant CJD (vCJD) based on clinical and diagnostic features.
  • To explore potential future diagnostic strategies for PrDs.

Main Methods:

  • Review of existing literature on human prion diseases, focusing on neuropathology and diagnostic criteria.

Related Experiment Videos

  • Comparison of diagnostic methods including post-mortem analysis (immunohistochemistry, Western blot), clinical symptoms, neuroimaging (MRI), electroencephalography (EEG), and cerebrospinal fluid (CSF) biomarkers.
  • Analysis of genetic factors (PRNP gene mutations, codon 129 polymorphism) influencing disease phenotype.

    • Main Results:

    • Definitive diagnosis of PrD requires post-mortem demonstration of PrPSc.
    • Clinical presentation, MRI, EEG, and CSF 14-3-3 protein levels aid in diagnosing probable CJD.
    • Variant CJD exhibits distinct clinical features, MRI findings (pulvinar sign), and diagnostic sensitivities compared to sporadic CJD.

    Conclusions:

    • Current diagnosis of human prion diseases relies on post-mortem confirmation or a combination of clinical and laboratory findings for probable cases.
    • Genetic factors significantly influence the clinical presentation and progression of prion diseases.
    • Future diagnostic advancements may involve detecting PrPSc in accessible body fluids or identifying novel laboratory and gene expression biomarkers.